Manning & Napier Advisors’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
Manning & Napier Advisors's ABBV Position: Q2 2026 in Review
Manning & Napier Advisors increased its AbbVie (ABBV) stake by 12,774% in Q2 2026, buying an estimated $18.2M and bringing the position to 85,352 shares worth $21.7M. The position accounts for 0.28% of the portfolio, ranked #64.
Manning & Napier Advisors first reported a position in ABBV in Q2 2013 and has held it in 18 quarters since. The position peaked at $22.7M in Q3 2017. 4,221 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Manning & Napier Advisors held 85,352 shares of AbbVie worth $21.7M as of Q2 2026.
- Manning & Napier Advisors bought 84,689 AbbVie shares in Q2 2026, an estimated $18.2M.
- AbbVie made up 0.28% of Manning & Napier Advisors's portfolio in Q2 2026, its #64 holding.
- Manning & Napier Advisors first reported a position in AbbVie in Q2 2013 and has held it in 18 quarters since.
- Manning & Napier Advisors's AbbVie position peaked at $22.7M in Q3 2017.
- 4,221 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Manning & Napier Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.